Your English writing platform
Discover LudwigSuggestions(1)
Exact(13)
A patient with abdominal pain, with a final diagnosis of a II assessing US, performed by EP. 82 year old woman, active and independent, who came to the ER with abdominal pain from 12 hours, which started about 2 hours after dinner.
It has been shown that trisomy 7 correlates with shorter survival of A II patients (Wessels et al, 2002).
Another reason for this controversy is that the interval after which malignant progression of A II occurs is difficult to predict.
Our study confirms previous studies of A II showing the prognostic value of patient age and symptoms at presentation (Lote et al, 1997; Bauman et al, 1999).
An important argument for not performing a stereotactic biopsy in these patients is that the histological diagnosis of A II does not alter treatment strategy.
The additional value of genetic and biological parameters to the current histological WHO classification was also seen in the three gemistocytic variants of A II.
Similar(47)
Direct renal actions of A-II to retain water in excess of sodium may also contribute.
We also treated the mice with ARB in addition to XTN and CDDP to increase the levels of A-II, which is unable to bind to AT1R.
While ACE inhibitors inhibit the conversion of A-I to A-II, ARBs selectively inhibit the binding of A-II to AT1 receptors.
Continuation of A-II blockade for treatment of HTN would have led to loss of GFR mostly on the affected side.
Regarding their pharmacological mechanism of action, ACE inhibitors have one advantage over ARBs, which cannot be neglected: by inhibiting the converting enzyme, they not only reduce the level of A-II, but also inhibit the degradation of bradykinin, hence enhancing the beneficial cardiovascular effects thereof.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com